The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
Clinical Trials Arena on MSN
The Bayesian challenge: complexity that pays off
The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.
The Simon two-stage minimax design is a popular statistical design used in Phase II clinical trials. The analysis of the data arising from the design typically involves the use of frequentist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results